BackEvotec SE Overview
Evotec SE - ADR

Evotec SE Target Price

Where could EVO trade next? Consensus target price: $3.

Get informed when a big investor buys or sells

+ Follow

Share Price

$1.82

Average Target Price

$3.0064.8% upside

2 analysts in the last 4 months

High: $4 | Low: $2

Analyst Recommendations

No recommendations in the last 4 months.

Revenue & Income Forecast

Analysts' Target Prices

DateAnalystPrice TargetCurrent Upside/Downside
2026-07-15H.C. WainwrightSwayampakula Ramakanth$4119.8% upsideOpen
2026-07-15Macquarie$29.9% upsideOpen
2025-08-14H.C. WainwrightDouglas Tsao$7284.6% upsideOpen
2024-08-15H.C. WainwrightDouglas Tsao$8339.6% upsideOpen
2024-04-25H.C. WainwrightDouglas Tsao$11504.4% upsideOpen
2022-12-09H.C. Wainwright$12559.3% upsideOpen

Evotec SE (EVO) FAQ

As of the most recent data, EVO shows a target price of $3. Scroll down for historical charts and peer comparison views.

If Evotec SE moved to the average analyst target of $3, shares would be roughly 64.8% higher than $1.82. Treat that as a sentiment and modeling checkpoint rather than a precise forecast, and weigh it against your own view of Evotec SE's earnings trajectory.

Besides this target price page, Stockcircle has Evotec SE's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect target price (currently $3) with ownership activity and broader fundamentals.

Evotec SE's target price is $3; compare it with other Healthcare names on the peer chart. Typical ranges vary by sub-industry, so always sanity-check against the closest competitors, not just the whole sector bucket.